OptimizeRx Q2 EPS $0.10 Beats $0.07 Estimate, Sales $13.60M Beat $12.45M Estimate

OptimizeRx (NASDAQ:OPRX) reported quarterly earnings of $0.10 per share which beat the analyst consensus estimate of $0.07 by 42.86 percent. This is a 400 percent increase over earnings of $0.02 per share from the same

OptimizeRx (NASDAQ:OPRX) reported quarterly earnings of $0.10 per share which beat the analyst consensus estimate of $0.07 by 42.86 percent. This is a 400 percent increase over earnings of $0.02 per share from the same period last year. The company reported quarterly sales of $13.60 million which beat the analyst consensus estimate of $12.45 million by 9.24 percent. This is a 54.84 percent increase over sales of $8.78 million the same period last year.

Total
0
Shares
Related Posts